ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China

Journal of Antimicrobial Chemotherapy

Volumn 66, Issue 2, 2011, Pages 307-312

  Qi, Yan ^a,b   Wei, Zeqing ^c   Ji, Shujuan ^a   Du, Xiaoxing ^a   Shen, Ping ^c   Yu, Yunsong ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b Hangzhou Hospital of Traditional Chinese Medicine   (China)

^c ZHEJIANG UNIVERSITY   (China)

Author keywords

Carbapenem resistance; MLST; PFGE; Plasmid; Transformation

Indexed keywords

AMIKACIN; BETA LACTAMASE; CARBAPENEM; CARBAPENEMASE; CEFOXITIN; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; PIPERACILLIN PLUS TAZOBACTAM; SULPERAZON;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHINA; GENETIC VARIABILITY; KLEBSIELLA PNEUMONIAE; MOLECULAR EPIDEMIOLOGY; NONHUMAN;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BLOTTING, SOUTHERN; CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PLASMIDS; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING;

EID: 78651433165     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq431     Document Type: Article

References (24)

1. Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis 2009; 9: 228-36.
2. Samuelsen Ø, Naseer U, Tofteland S et al. Emergence of clonally related Klebsiella pneumoniae isolates of sequence type 258 producing plasmid-mediated KPC carbapenemase in Norway and Sweden. J Antimicrob Chemother 2009; 63: 654-8.
3. Cuzon G, Naas T, Demachy MC et al. Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother 2008; 52: 796-7.
4. Robledo IE, Aquino EE, Santé MI et al. Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother 2010; 54: 1354-7.
5. Wei ZQ, Du XX, Yu YS et al. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother 2007; 51: 763-5.
6. Baraniak A, Izdebski R, Herda M et al. The emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland. Antimicrob Agents Chemother 2009; 53: 4565-7.
7. Chmelnitsky I, Hermesh O, Navon-Venezia S et al. Detection of aac(6′)-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. J Antimicrob Chemother 2009; 64: 718-22.
8. Osterblad M, Kirveskari J, Koskela S et al. First isolations of KPC-2-carrying ST258 Klebsiella pneumoniae strains in Finland, June and August 2009. Euro Surveill 2009; 14: 19349.
9. Fontana C, Favaro M, Sarmati L et al. Emergence of KPC-producing Klebsiella pneumoniae in Italy. BMC Res Notes 2010; 3: 40.
10. Wendt C, Schütt S, Dalpke AH et al. First outbreak of Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae in Germany. Eur J Clin Microbiol Infect Dis 2010; 29: 563-70.
11. Hammerum AM, Hansen F, Lester CH et al. Detection of the first two Klebsiella pneumoniae isolates with sequence type 258 producing KPC-2 carbapenemase in Denmark. Int J Antimicrob Agents 2010; 35: 610-2.
12. Tóth A, Damjanova I, Puskás E et al. Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in Hungary. Eur J Clin Microbiol Infect Dis 2010; 29: 765-9.
13. Kitchel B, Rasheed JK, Patel JB et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53: 3365-70.
14. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: M100-S20-U. CLSI, Wayne, PA, USA, 2010.
15. Gales AC, Reis AO, Jones RN. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines. J Clin Microbiol 2001; 39: 183-90.
16. Gouby A, Neuwirth C, Bourg G et al. Epidemiological study by pulsed-field gel electrophoresis of an outbreak of extended-spectrum beta-lactamase producing Klebsiella pneumoniae in a geriatric hospital. J Clin Microbiol 1994; 32: 301-5.
17. Hunter SB, Vauterin P, Lambert-Fair MA et al. Establishment of a universal size standard strain for use with the PulseNet standardized pulsed-field gel electrophoresis protocols: converting the national databases to the new size standard. J Clin Microbiol 2005; 43: 1045-50.
18. Pérez-Pérez FJ, Hanson ND. Detection of plasmid-mediated AmpC b-lactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 2002; 40: 2153-62.
19. Shen P, Wei ZQ, Jiang Y et al. Novel genetic environment of the carbapenem-hydrolyzing b-lactamase KPC-2 among Enterobacteriaceae in China. Antimicrob Agents Chemother 2009; 10: 4333-8.
20. Willems RJ, Top J, Van Santen M et al. Global spread of vancomycin-resistant Enterococcus faecium from distinct nosocomial genetic complex. Emerg Infect Dis 2005; 11: 821-8.
21. Fu Y, Zhou J, Zhou H et al. Wide dissemination of OXA-23-producing carbapenem-resistant Acinetobacter baumannii clonal complex 22 in multiple cities of China. J Antimicrob Chemother 2010; 65: 644-50.
22. Rhee JY, Park YK, Shin JY et al. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother 2010; 54: 2278-9.
23. Damjanova I, Toth A, Paszti J et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type b-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005-the new 'MRSAs'? J Antimicrob Chemother 2008; 62: 978-85.
24. Yu YS, Ji SJ, Chen YG et al. Resistance of strains producing extended-spectrum beta-lactamases and genotype distribution in China. J Infect 2007; 54:53-7.